Retrograde ejaculation and loss of emission: possibilities of conservative treatment.
Twenty-five patients with retrograde ejaculation/loss of emission were treated with ephedrine sulfate or imipramine hydrochloride. Seventeen of them suffering from both diabetes and retrograde ejaculation were treated with ephedrine or, in case that ephedrine failed to convert retrograde ejaculation into anterograde ejaculation, with imipramine. Positive results were obtained in 5/17 (29.3%) patients, i.e. in 3 (17.6%) and 2 (11.7%) patients on ephedrine and imipramine, respectively. The daily dose of ephedrine was 50 mg and that of imipramine 75 mg, during a 4-week period. In the group with retroperitoneal lymphadenectomy, after treatment with ephedrine, only 1 (12.5%) had retrograde ejaculation while the remaining patients (n = 7) continued to lack semen emission. These 7 patients were treated with imipramine, and 3 of them (42.8%) achieved anterograde ejaculation. In one third of patients with retroperitoneal lymphadenectomy and diabetes, with retrograde ejaculation or loss of semen emission, conservative treatment can offer improvement or conversion to anterograde ejaculation.
Gilja
I
I
Department of Urology, General Hospital (Sveti Duh), Zagreb, Croatia.
Parazajder
J
J
Radej
M
M
Cvitković
P
P
Kovacić
M
M
D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004542:Ejaculation; D004809:Ephedrine / Q000627:therapeutic use*; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008197:Lymph Node Excision / Q000009:adverse effects; D008297:Male; D012187:Retroperitoneal Space; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000209:etiology
D004809:Ephedrine; D007099:Imipramine